Media Release Marking Immutep's transition to a Phase III biotech, the Company's pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regulatory approvalMature da ...
President Donald Trump' s most controversial Cabinet nominees — Robert F. Kennedy Jr., Tulsi Gabbard and Kash Patel — flooded the zone Thursday in back-to-back-to-back confirmation hearings that were ...